Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Minerva Neurosciences (NERV)
NASDAQ:NERV
Holding NERV?
Track your performance easily
NERV Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.26 - $13.49
Previous Close$2.36
Volume31.28K
Average Volume (3M)17.66K
Market Cap
$16.22M
Enterprise Value-$10.30M
Total Cash (Recent Filing)$26.53M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta2.60
Next Earnings
Mar 18, 2025EPS Estimate
-$1.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.45
Shares Outstanding6,993,406
10 Day Avg. Volume37,405
30 Day Avg. Volume17,658
Standard Deviation0.53
R-Squared0.00027
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)-0.36
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda-5.92
Forecast
1Y Price Target
$5.00Price Target Upside116.45% Upside
Rating ConsensusHold
Number of Analyst Covering1
Minerva Neurosciences News
PremiumCompany Announcements
Minerva Neurosciences Reports Positive Earnings Amid FDA Challenges
PremiumPre-Earnings
Is NERV a Buy, Before Earnings?
PremiumCompany Announcements
Minerva Neurosciences Announces Board and Audit Committee Changes
Ownership Overview
―
Insiders
21.21% Mutual Funds
<0.01% Other Institutional Investors
75.21% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
NERV FAQ
What was Minerva Neurosciences’s price range in the past 12 months?
Minerva Neurosciences lowest stock price was $2.26 and its highest was $13.49 in the past 12 months.
What is Minerva Neurosciences’s market cap?
Currently, no data Available
When is Minerva Neurosciences’s upcoming earnings report date?
Minerva Neurosciences’s upcoming earnings report date is Mar 18, 2025 which is in 130 days.
How were Minerva Neurosciences’s earnings last quarter?
Minerva Neurosciences released its earnings results on Nov 05, 2024. The company reported $2.97 earnings per share for the quarter, beating the consensus estimate of -$1.01 by $3.98.
Is Minerva Neurosciences overvalued?
According to Wall Street analysts Minerva Neurosciences’s price is currently Undervalued.
Does Minerva Neurosciences pay dividends?
Minerva Neurosciences does not currently pay dividends.
What is Minerva Neurosciences’s EPS estimate?
Minerva Neurosciences’s EPS estimate is -$1.05.
How many shares outstanding does Minerva Neurosciences have?
Minerva Neurosciences has 6,993,406 shares outstanding.
What happened to Minerva Neurosciences’s price movement after its last earnings report?
Minerva Neurosciences reported an EPS of $2.97 in its last earnings report, beating expectations of -$1.01. Following the earnings report the stock price went up 1.724%.
Which hedge fund is a major shareholder of Minerva Neurosciences?
Currently, no hedge funds are holding shares in NERV
---
Minerva Neurosciences Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$5.00 (116.45% Upside)
$5.00 (116.45% Upside)
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 8.6%
Last 30 Days ▼ 8.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-57.16%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-32.18%
Trailing 12-Months
Company Description
Minerva Neurosciences
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. Its product pipeline includes Roluperidone, Seltorexant, MIN-117, and MIN-301. The company was founded by Rogerio Vivaldi Coelho on April 23, 2007 and is headquartered in Cambridge, MA.
---
NERV Earnings Call
Q1 2023
0:00 / 0:00
---
NERV Stock 12 Month Forecast
Average Price Target
$5.00
▲(116.45% Upside)
Technical Analysis
ACADIA Pharmaceuticals
―
SAGE Therapeutics
―
Axsome Therapeutics
―
Viking Therapeutics
―
---